What is Nutriband's operating income?

Nutriband's total operating income in 2026 was -$8.32 million, based on the following breakdown: Total Gross Profit: $566.31 thousand Total Operating Expenses: $8.88 million

Nutriband (NTRB) Financials

$3.13 +0.08 (+2.62%)

Closing price 07/16/2026 04:00 PM Eastern

Extended Trading

$3.10 -0.02 (-0.80%)

As of 07/16/2026 05:19 PM Eastern

Compare

Annual Income Statements for Nutriband

This table shows Nutriband's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	1/31/2017	1/31/2018	1/31/2019	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025	1/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-0.15	-2.67	-3.33	-2.72	-2.93	-6.37	-4.48	-5.49	-10	-30
Consolidated Net Income / (Loss)	-0.15	-2.67	-3.33	-2.72	-2.93	-6.18	-4.48	-5.49	-10	-8.23
Net Income / (Loss) Continuing Operations	-0.15	-2.67	-3.33	-2.72	-2.93	-6.18	-4.48	-5.49	-10	-8.23
Total Pre-Tax Income	-0.15	-2.67	-3.33	-2.72	-2.93	-6.18	-4.48	-5.49	-10	-8.23
Total Operating Income	-0.15	-2.67	-3.33	-1.97	-2.60	-6.11	-4.48	-4.87	-10	-8.32
Total Gross Profit	0.00	0.00	-0.04	-0.18	0.32	0.50	0.75	0.86	0.74	0.57
Total Revenue	0.00	0.00	0.25	0.37	0.94	1.42	2.08	2.09	2.14	2.04
Operating Revenue	0.00	0.00	0.25	0.37	0.94	1.42	2.08	2.09	2.14	2.04
Total Cost of Revenue	0.00	0.00	0.29	0.55	0.63	0.92	1.33	1.22	1.40	1.47
Operating Cost of Revenue	-	0.00	0.29	0.55	0.63	0.92	1.33	1.22	1.40	1.47
Total Operating Expenses	0.15	2.67	3.29	1.79	2.91	6.62	5.23	5.73	11	8.88
Selling, General & Admin Expense	0.15	0.17	3.29	1.79	2.91	4.02	3.92	3.77	4.31	6.99
Research & Development Expense	-	-	-	-	0.00	0.41	0.98	1.96	3.12	1.89
Impairment Charge	0.00	2.50	-	-	0.00	2.18	0.33	0.00	3.60	0.00
Total Other Income / (Expense), net	0.00	0.00	0.00	-0.75	-0.34	-0.07	-0.02	-0.61	-0.20	0.09
Interest Expense	-	-	0.00	0.07	0.28	0.07	0.01	0.63	0.39	0.02
Interest & Investment Income	-	-	-	-	-	-	0.00	0.02	0.19	0.11
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Stock Dividends Declared	-	-	-	-	0.00	0.20	-	-	0.00	22
Basic Earnings per Share	($0.01)	($0.14)	($0.62)	($0.50)	($0.51)	($0.80)	($0.53)	($0.69)	($0.99)	($2.58)
Weighted Average Basic Shares Outstanding	21.21M	19.21M	5.35M	5.42M	5.77M	7.93M	8.46M	7.95M	10.61M	11.64M
Diluted Earnings per Share	($0.01)	($0.14)	($0.62)	($0.50)	-	-	-	($0.69)	($0.99)	($2.58)
Weighted Average Diluted Shares Outstanding	21.21M	19.21M	5.35M	5.42M	5.77M	7.82M	7.83M	7.95M	10.61M	11.64M
Weighted Average Basic & Diluted Shares Outstanding	21.21M	19.21M	5.35M	5.42M	5.77M	7.82M	7.83M	10.97M	11.15M	12.16M

This table shows Nutriband's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q2 2024	Q3 2024	Q1 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026	Q1 2027
Period end date	7/31/2023	7/31/2024	10/31/2023	4/30/2024	10/31/2024	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026
Net Income / (Loss) Attributable to Common Shareholders	-0.83	-1.71	-1.76	-1.90	-1.36	-1.39	-24	-3.87	-0.97	-1.24
Consolidated Net Income / (Loss)	-0.83	-1.71	-1.76	-1.90	-1.36	-1.39	-2.00	-3.87	-0.97	-1.24
Net Income / (Loss) Continuing Operations	-0.83	-1.71	-1.76	-1.90	-1.36	-1.39	-2.00	-3.87	-0.97	-1.24
Total Pre-Tax Income	-0.83	-1.71	-1.76	-1.90	-1.36	-1.39	-2.00	-3.87	-0.97	-1.24
Total Operating Income	-0.82	-1.41	-1.72	-1.89	-1.43	-1.41	-2.00	-3.88	-1.02	-1.25
Total Gross Profit	0.30	0.10	0.16	0.16	0.19	0.25	0.16	0.07	0.09	0.20
Total Revenue	0.66	0.44	0.43	0.41	0.65	0.67	0.62	0.35	0.40	0.43
Operating Revenue	0.66	0.44	0.43	0.41	0.65	0.67	0.62	0.35	0.40	0.43
Total Cost of Revenue	0.36	0.34	0.27	0.24	0.45	0.42	0.47	0.28	0.31	0.24
Operating Cost of Revenue	0.36	0.34	0.27	0.24	0.45	0.42	0.47	0.28	0.31	0.24
Total Operating Expenses	1.12	1.51	1.88	2.05	1.62	1.67	2.16	3.95	1.11	1.45
Selling, General & Admin Expense	0.68	0.74	1.33	1.08	0.74	0.98	1.60	3.49	0.92	1.20
Research & Development Expense	0.45	0.77	0.55	0.97	0.88	0.68	0.56	0.46	0.19	0.25
Total Other Income / (Expense), net	-0.00	-0.30	-0.04	-0.01	0.06	0.02	0.00	0.01	0.05	0.01
Interest Expense	0.01	0.37	0.04	0.01	0.00	0.01	0.01	0.01	0.01	0.01
Other Income / (Expense), net	-	-	-	-	-	0.03	-	-	-	0.02
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Preferred Stock Dividends Declared	-	0.00	-	-	0.00	0.00	22	0.00	-	0.00
Basic Earnings per Share	($0.11)	($0.15)	($0.22)	($0.21)	($0.12)	($0.12)	($2.12)	($0.32)	($0.02)	($0.10)
Weighted Average Basic Shares Outstanding	7.83M	11.06M	7.83M	9.16M	11.10M	11.13M	11.22M	12.06M	11.64M	12.16M
Diluted Earnings per Share	-	($0.15)	($0.22)	($0.21)	($0.12)	($0.12)	($2.12)	($0.32)	($0.02)	($0.10)
Weighted Average Diluted Shares Outstanding	7.83M	11.06M	7.83M	9.16M	11.10M	11.13M	11.22M	12.06M	11.64M	12.16M
Weighted Average Basic & Diluted Shares Outstanding	7.83M	11.10M	7.83M	11.04M	11.11M	11.15M	12.03M	12.17M	12.16M	12.16M

This table details how cash moves in and out of Nutriband's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	1/31/2017	1/31/2018	1/31/2019	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025	1/31/2026
Net Change in Cash & Equivalents	0.03	-0.03	0.47	-0.46	0.14	4.74	-2.91	-1.49	3.82	0.26
Net Cash From Operating Activities	-0.15	-0.09	-1.11	-0.89	-0.30	-2.81	-2.99	-3.53	-4.63	-5.13
Net Cash From Continuing Operating Activities	-0.15	-0.09	-1.11	-0.89	-0.30	-2.81	-2.99	-3.53	-4.63	-5.13
Net Income / (Loss) Continuing Operations	-0.15	-2.67	-3.33	-2.72	-2.93	-6.18	-4.48	-5.49	-10	-8.23
Consolidated Net Income / (Loss)	-0.15	-2.67	-3.33	-2.72	-2.93	-6.18	-4.48	-5.49	-10	-8.23
Depreciation Expense	-	0.00	0.04	0.07	0.16	0.31	0.33	0.29	0.29	0.19
Non-Cash Adjustments To Reconcile Net Income	0.01	2.50	1.79	0.94	2.08	3.49	1.39	1.45	5.54	2.77
Changes in Operating Assets and Liabilities, net	-0.00	0.08	0.40	0.73	0.11	-0.54	-0.22	0.22	0.03	0.13
Net Cash From Investing Activities	0.00	0.00	-0.40	0.00	0.07	-0.08	-0.08	-0.05	-0.09	-0.01
Net Cash From Continuing Investing Activities	0.00	0.00	-0.40	0.00	0.07	-0.08	-0.08	-0.05	-0.09	-0.01
Purchase of Property, Plant & Equipment	-	-	-0.00	-	0.00	-0.08	-0.08	-0.05	-0.09	-0.01
Net Cash From Financing Activities	0.17	0.07	1.98	0.43	0.37	7.63	0.16	2.09	8.54	5.40
Net Cash From Continuing Financing Activities	0.17	0.07	1.98	0.43	0.37	7.63	0.16	2.09	8.54	5.40
Repayment of Debt	-0.02	-0.01	-0.04	-0.03	-0.40	-1.51	-0.02	-0.02	-0.02	-0.02
Repurchase of Common Equity	-	-	-	-	0.00	-0.10	-0.12	0.00	-0.15	0.00
Issuance of Debt	0.02	0.02	0.03	0.46	0.20	-	0.00	2.11	0.30	0.00
Issuance of Common Equity	0.18	0.05	2.00	0.00	0.52	9.36	-	0.00	8.41	5.31
Other Financing Activities, net	-	0.00	-	0.00	0.05	-0.12	0.30	-	0.00	0.12
Cash Interest Paid	0.00	0.00	0.00	0.00	0.01	0.02	0.00	0.01	0.01	0.00
Cash Income Taxes Paid	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

This table details how cash moves in and out of Nutriband's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2024	Q4 2024	Q1 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026	Q1 2027
Period end date	7/31/2023	10/31/2023	1/31/2024	4/30/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026
Net Change in Cash & Equivalents	1.06	-6.99	-0.77	7.85	-1.39	-1.35	4.03	-1.68	-0.74	-0.57
Net Cash From Operating Activities	-1.00	-0.43	-0.72	-0.83	-1.24	-1.34	-1.31	-1.75	-0.73	-0.56
Net Cash From Continuing Operating Activities	-1.01	-0.44	-0.69	-0.83	-1.24	-1.34	-1.31	-1.75	-0.73	-0.56
Net Income / (Loss) Continuing Operations	-0.83	-0.00	-1.88	-1.90	-5.52	-1.39	-2.00	-3.87	-0.97	-1.24
Consolidated Net Income / (Loss)	-0.83	-0.00	-1.88	-1.90	-5.52	-1.39	-2.00	-3.87	-0.97	-1.24
Depreciation Expense	0.08	0.08	0.07	0.07	0.07	0.06	0.06	0.04	0.04	0.03
Non-Cash Adjustments To Reconcile Net Income	0.01	-0.17	0.69	0.42	4.46	0.07	0.06	2.54	0.11	0.56
Changes in Operating Assets and Liabilities, net	-0.27	-0.35	0.42	0.57	-0.25	-0.08	0.57	-0.47	0.09	0.08
Net Cash From Investing Activities	-	0.04	-0.05	-0.01	-	-0.01	-	-	-	0.00
Net Cash From Continuing Investing Activities	-	0.04	-0.05	-0.01	-	-0.01	-	-	-	0.00
Purchase of Property, Plant & Equipment	-	0.04	-0.05	-0.01	-	-0.01	-	-	-	0.00
Net Cash From Financing Activities	2.05	-6.60	-0.01	8.69	-0.15	-0.01	5.34	0.07	-0.01	-0.01
Net Cash From Continuing Financing Activities	2.05	-6.60	-0.01	8.69	-0.15	-0.01	5.34	0.07	-0.01	-0.01
Repayment of Debt	-0.00	-0.00	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Repurchase of Common Equity	-	-	-	-	-	0.00	-	-	-	0.00
Issuance of Debt	2.06	1.81	-	0.30	-	0.00	-	-	-	0.00
Issuance of Common Equity	-	-8.40	-	8.40	0.01	0.00	5.31	-	-	0.00
Other Financing Activities, net	-	-0.00	-	0.00	-	0.00	0.04	0.08	-	0.00
Cash Interest Paid	0.00	0.01	-	0.00	0.01	0.00	0.00	-	-	0.00
Cash Income Taxes Paid	-	-0.00	-	0.00	-0.00	0.00	-	-	-	0.00

This table presents Nutriband's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	1/31/2016	1/31/2017	1/31/2018	1/31/2019	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025	1/31/2026
Total Assets	0.00	0.04	0.16	2.81	2.20	9.93	13	9.46	7.52	7.47	7.55
Total Current Assets	0.00	0.04	0.16	0.59	0.04	0.31	5.47	2.69	1.02	4.79	4.99
Cash & Equivalents	0.00	0.03	0.00	0.47	0.01	0.15	4.89	1.99	0.49	4.31	4.57
Accounts Receivable	-	-	0.00	0.01	0.01	0.11	0.07	0.11	0.15	0.07	0.12
Inventories, net	0.00	0.01	0.00	-	0.00	0.05	0.13	0.23	0.17	0.21	0.12
Prepaid Expenses	0.00	0.00	0.16	0.10	0.02	0.00	0.37	0.37	0.21	0.20	0.18
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.15	0.11	1.08	0.98	0.90	0.77	0.70	0.57
Total Noncurrent Assets	0.00	0.00	0.00	2.07	2.04	8.54	6.29	5.86	5.72	1.98	1.99
Goodwill	-	-	0.00	1.72	1.72	7.53	5.35	5.02	5.02	1.72	1.72
Intangible Assets	-	-	0.00	0.35	0.31	1.01	0.93	0.78	0.67	0.26	0.20
Other Noncurrent Operating Assets	-	-	-	0.00	0.01	0.00	0.02	0.06	0.03	0.00	0.07
Total Liabilities & Shareholders' Equity	0.00	0.04	0.16	2.81	2.20	9.93	13	9.46	7.52	7.47	7.55
Total Liabilities	0.01	0.01	0.04	0.40	2.02	2.82	0.88	0.88	1.08	1.04	0.87
Total Current Liabilities	0.01	0.01	0.04	0.40	2.02	2.57	0.78	0.75	1.00	0.98	0.78
Short-Term Debt	0.00	0.00	0.02	0.04	0.31	1.52	0.01	0.02	0.13	0.13	0.13
Accounts Payable	0.01	0.01	0.03	0.29	0.77	0.94	0.64	0.53	0.68	0.70	0.50
Current Deferred Revenue	-	-	-	-	0.00	0.09	0.11	0.16	0.16	0.16	0.12
Other Current Liabilities	-	0.00	-	0.00	0.94	0.02	0.02	0.03	0.03	0.00	0.03
Total Noncurrent Liabilities	0.00	0.00	0.00	0.00	0.00	0.25	0.10	0.13	0.08	0.06	0.08
Long-Term Debt	0.00	-	-	-	0.00	0.15	0.10	0.10	0.08	0.06	0.04
Other Noncurrent Operating Liabilities	-	-	-	-	0.00	0.10	0.00	0.03	-	0.00	0.05
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-0.01	0.02	0.12	2.40	0.18	7.11	12	8.57	6.44	6.43	6.68
Total Preferred & Common Equity	-0.01	0.02	0.12	2.40	0.18	7.11	12	8.57	6.44	6.43	6.68
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-0.01	0.02	0.12	2.40	0.18	7.11	12	8.57	6.44	6.43	6.68
Common Stock	0.01	0.20	2.97	8.59	9.08	19	30	31	34	45	53
Retained Earnings	-0.03	-0.18	-2.85	-6.18	-8.90	-12	-18	-22	-28	-38	-47
Treasury Stock	-	-	-	-	-	-	-0.10	-0.03	-0.03	-0.15	-0.09
Accumulated Other Comprehensive Income / (Loss)	0.00	0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00

This table presents Nutriband's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q2 2024	Q3 2024	Q1 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026	Q1 2027
Period end date	7/31/2023	7/31/2024	10/31/2023	4/30/2024	10/31/2024	4/30/2025	7/31/2025	10/31/2025	4/30/2026
Total Assets	9.87	14	8.52	15	13	6.15	10	8.42	6.89
Total Current Assets	3.27	7.25	2.00	8.73	6.19	3.43	7.52	5.82	4.38
Cash & Equivalents	2.33	6.76	1.27	8.35	5.70	2.96	7.00	5.31	4.01
Accounts Receivable	0.22	0.07	0.17	0.09	0.11	0.09	0.16	0.15	0.00
Inventories, net	0.16	0.22	0.17	0.17	0.17	0.22	0.14	0.14	0.12
Prepaid Expenses	0.56	0.20	0.39	0.13	0.22	0.16	0.23	0.22	0.25
Plant, Property, & Equipment, net	0.81	0.74	0.77	0.74	0.74	0.66	0.62	0.59	0.55
Total Noncurrent Assets	5.79	5.65	5.76	5.68	5.61	2.06	2.04	2.02	1.97
Goodwill	5.02	5.02	5.02	5.02	5.02	1.72	1.72	1.72	1.72
Intangible Assets	0.72	0.61	0.70	0.64	0.58	0.25	0.23	0.22	0.19
Other Noncurrent Operating Assets	0.05	0.02	0.04	0.02	0.01	0.10	0.09	0.08	0.06
Total Liabilities & Shareholders' Equity	9.87	14	8.52	15	13	6.15	10	8.42	6.89
Total Liabilities	2.98	1.17	2.81	1.79	1.31	1.05	1.68	0.87	0.90
Total Current Liabilities	0.87	1.10	0.72	1.42	1.25	0.93	1.57	0.77	0.83
Short-Term Debt	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13
Accounts Payable	0.50	0.78	0.39	0.99	0.89	0.72	1.39	0.61	0.64
Current Deferred Revenue	0.22	0.18	0.17	0.27	0.22	0.04	0.02	0.01	0.03
Other Current Liabilities	0.03	0.02	0.03	0.03	0.01	0.03	0.03	0.03	0.03
Total Noncurrent Liabilities	2.11	0.07	2.09	0.37	0.06	0.12	0.11	0.10	0.07
Long-Term Debt	2.09	0.07	0.09	0.07	0.06	0.05	0.05	0.04	0.03
Other Noncurrent Operating Liabilities	0.02	-	2.01	0.30	-	0.07	0.06	0.06	0.04
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	6.89	12	5.71	13	11	5.10	8.49	7.55	5.99
Total Preferred & Common Equity	6.89	12	5.71	13	11	5.10	8.49	7.55	5.99
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	6.89	12	5.71	13	11	5.10	8.49	7.55	5.99
Common Stock	31	44	32	43	44	45	50	53	54
Retained Earnings	-24	-32	-26	-30	-33	-40	-42	-46	-48
Treasury Stock	-0.03	-0.03	-0.03	-0.03	0.00	-0.11	-0.09	-0.09	-0.09
Accumulated Other Comprehensive Income / (Loss)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00

This table displays calculated financial ratios and metrics derived from Nutriband's official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	1/31/2017	1/31/2018	1/31/2019	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025	1/31/2026
DEI Shares Outstanding	22,525,000.00	20,767,100.00	21,824,100.00	5,423,956.00	6,126,447.00	7,773,962.00	7,833,151.00	7,833,150.00	11,106,185.00	11,154,171.00
DEI Adjusted Shares Outstanding	26,279,167.00	24,228,283.00	25,461,450.00	6,327,949.00	7,147,522.00	9,069,622.00	7,833,151.00	7,833,150.00	11,106,185.00	11,154,171.00
DEI Earnings Per Adjusted Shares Outstanding	-0.01	-0.11	-0.13	-0.43	-0.41	-0.70	-0.57	-0.70	-0.94	-2.69
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	51.11%	154.61%	50.70%	46.23%	0.27%	2.60%	-4.81%
EBITDA Growth	0.00%	-1,666.46%	-23.29%	24.43%	11.21%	-157.66%	27.07%	-10.37%	-118.14%	18.76%
EBIT Growth	0.00%	-1,666.46%	-24.67%	20.50%	-0.15%	-130.41%	26.63%	-8.66%	-111.10%	19.12%
NOPAT Growth	0.00%	-1,666.46%	-24.67%	40.88%	-31.81%	-135.40%	26.77%	-8.87%	-111.10%	19.12%
Net Income Growth	0.00%	-1,666.46%	-24.67%	18.30%	-7.76%	-110.59%	27.41%	-22.35%	-91.10%	21.49%
EPS Growth	0.00%	-1,300.00%	-342.86%	19.35%	0.00%	0.00%	0.00%	0.00%	-43.48%	-160.61%
Operating Cash Flow Growth	0.00%	37.23%	-1,090.49%	19.09%	66.79%	-845.69%	-6.34%	-18.09%	-31.16%	-10.98%
Free Cash Flow Firm Growth	0.00%	0.00%	-107.02%	102.75%	-8,802.17%	72.57%	-0.88%	-3.52%	-17.37%	-72.76%
Invested Capital Growth	0.00%	5,783.16%	1,324.12%	-75.80%	1,709.16%	-17.90%	-5.29%	-8.28%	-62.56%	-1.48%
Revenue Q/Q Growth	0.00%	0.00%	-31.18%	123.65%	19.89%	-3.09%	6.32%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	-890.02%	39.30%	-95.65%	-34.90%	-23.10%	23.60%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	-890.02%	38.04%	-100.87%	-31.01%	-19.69%	22.24%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	-890.02%	38.04%	-49.39%	-44.96%	-19.69%	22.38%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	-890.02%	38.04%	-35.64%	-54.85%	-13.43%	22.64%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	-600.00%	10.14%	-35.14%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	18.22%	-32.56%	15.60%	10.38%	-69.24%	12.29%	2.64%	-12.69%	8.99%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	-16.73%	0.35%	-11.77%	26.05%	-29.72%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	-94.24%	-10.57%	-59.10%	-2.30%	-20.88%	-4.75%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	-17.54%	-48.15%	33.52%	35.46%	36.08%	41.34%	34.74%	27.81%
EBITDA Margin	0.00%	0.00%	-1,343.02%	-671.61%	-234.22%	-400.45%	-199.72%	-219.83%	-467.38%	-398.90%
Operating Margin	0.00%	0.00%	-1,358.11%	-531.35%	-275.08%	-429.68%	-215.19%	-233.63%	-480.70%	-408.41%
EBIT Margin	0.00%	0.00%	-1,358.11%	-714.48%	-281.04%	-429.68%	-215.59%	-233.63%	-480.70%	-408.41%
Profit (Net Income) Margin	0.00%	0.00%	-1,358.11%	-734.29%	-310.78%	-434.28%	-215.59%	-263.05%	-489.95%	-404.08%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	100.00%	100.00%	100.00%	102.77%	110.58%	101.07%	100.00%	112.59%	101.92%	98.94%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	-221.21%	-112.69%	-39.92%	-54.46%	-45.43%	-53.04%	-170.28%	-254.66%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	257.15%	1,902.84%	-162.80%	61.94%	-4.76%	139.88%	-21.43%	-198.25%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	-42.53%	-98.29%	-40.57%	-10.65%	1.55%	-20.05%	7.35%	129.09%
Return on Equity (ROE)	-2,599.19%	-3,695.20%	-263.74%	-210.98%	-80.49%	-65.11%	-43.89%	-73.08%	-162.94%	-125.56%
Cash Return on Invested Capital (CROIC)	0.00%	-1,453.88%	-394.97%	9.36%	-218.97%	-34.80%	-40.00%	-44.40%	-79.25%	-253.16%
Operating Return on Assets (OROA)	0.00%	0.00%	-224.14%	-105.81%	-43.75%	-53.92%	-40.40%	-57.41%	-137.25%	-110.77%
Return on Assets (ROA)	0.00%	0.00%	-224.14%	-108.75%	-48.38%	-54.49%	-40.40%	-64.63%	-139.89%	-109.60%
Return on Common Equity (ROCE)	-2,599.19%	-3,695.20%	-263.74%	-210.98%	-80.49%	-65.11%	-43.89%	-73.08%	-162.94%	-125.53%
Return on Equity Simple (ROE_SIMPLE)	-654.55%	-2,198.99%	-138.54%	-1,551.38%	-41.24%	-52.08%	-52.30%	-85.20%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-0.11	-1.87	-2.33	-1.38	-1.82	-4.28	-3.13	-3.41	-7.20	-5.82
NOPAT Margin	0.00%	0.00%	-950.68%	-371.95%	-192.56%	-300.78%	-150.64%	-163.54%	-336.49%	-285.89%
Net Nonoperating Expense Percent (NNEP)	-177.65%	-18,378.63%	-478.36%	-2,015.53%	122.88%	-116.40%	-40.68%	-192.92%	-148.86%	-56.40%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-51.32%	-108.83%	-85.07%
Cost of Revenue to Revenue	0.00%	0.00%	117.54%	148.15%	66.48%	64.54%	63.92%	58.66%	65.26%	72.19%
SG&A Expenses to Revenue	0.00%	0.00%	1,340.57%	483.20%	308.60%	282.87%	188.31%	180.96%	201.62%	343.36%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	28.93%	47.23%	94.01%	145.79%	92.85%
Operating Expenses to Revenue	0.00%	0.00%	1,340.57%	483.20%	308.60%	465.14%	251.28%	274.97%	515.45%	436.22%
Earnings before Interest and Taxes (EBIT)	-0.15	-2.67	-3.33	-2.65	-2.65	-6.11	-4.48	-4.87	-10	-8.32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-0.15	-2.67	-3.29	-2.49	-2.21	-5.69	-4.15	-4.58	-10.00	-8.12
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	59.45	425.12	9.26	2.86	3.34	3.18	14.32	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	428.49	0.00	0.00	6.08	10.32	27.29	20.70	0.00
Price to Revenue (P/Rev)	0.00	0.00	582.78	201.21	69.79	23.89	13.75	9.80	43.03	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	72.34	157.04	7.81	4.12	3.98	3.28	38.18	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	581.01	202.03	71.39	20.53	12.85	9.67	41.10	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	653.80	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.07	0.14	0.02	1.78	0.23	0.01	0.01	0.03	0.03	0.02
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.02	0.01	0.01	0.01	0.01	0.01
Financial Leverage	-1.11	-0.06	-0.17	-0.05	0.25	-0.17	-0.33	-0.14	-0.34	-0.65
Leverage Ratio	3.27	1.40	1.18	1.94	1.66	1.19	1.09	1.13	1.16	1.15
Compound Leverage Factor	3.27	1.40	1.18	1.99	1.84	1.21	1.09	1.27	1.19	1.13
Debt to Total Capital	6.40%	12.16%	1.64%	63.98%	18.98%	0.96%	1.38%	3.12%	2.82%	2.41%
Short-Term Debt to Total Capital	6.40%	12.16%	1.64%	63.98%	17.27%	0.12%	0.23%	1.91%	1.94%	1.88%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	1.71%	0.84%	1.16%	1.20%	0.88%	0.52%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	93.60%	87.84%	98.36%	36.02%	81.02%	99.04%	98.62%	96.88%	97.18%	97.55%
Debt to EBITDA	-0.01	-0.01	-0.01	-0.13	-0.75	-0.02	-0.03	-0.05	-0.02	-0.02
Net Debt to EBITDA	0.17	-0.01	0.13	-0.12	-0.69	0.84	0.45	0.06	0.41	0.54
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	-0.07	-0.02	-0.02	-0.02	-0.01	0.00
Debt to NOPAT	-0.01	-0.01	-0.02	-0.23	-0.92	-0.03	-0.04	-0.06	-0.03	-0.03
Net Debt to NOPAT	0.24	-0.01	0.19	-0.22	-0.83	1.12	0.60	0.08	0.57	0.76
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	-0.08	-0.02	-0.03	-0.02	-0.01	-0.01
Altman Z-Score	0.00	0.00	205.99	11.57	11.31	20.14	14.99	4.30	42.21	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.02%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.58	3.80	1.47	0.02	0.12	7.01	3.60	1.02	4.88	6.36
Quick Ratio	1.86	0.00	1.21	0.01	0.10	6.37	2.80	0.64	4.46	5.98
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-2.01	-4.16	0.11	-9.97	-2.73	-2.76	-2.85	-3.35	-5.79
Operating Cash Flow to CapEx	0.00%	0.00%	-26,554.55%	0.00%	0.00%	-3,442.89%	-3,766.77%	-6,814.99%	-5,026.52%	-96,443.09%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	1.56	-35.51	-41.80	-332.70	-4.53	-8.60	-256.86
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	-12.18	-1.06	-42.96	-360.38	-5.60	-11.88	-227.85
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	-12.18	-1.06	-44.21	-369.95	-5.68	-12.12	-228.09
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.17	0.15	0.16	0.13	0.19	0.25	0.29	0.27
Accounts Receivable Turnover	0.00	0.00	0.00	28.60	15.45	15.74	22.55	15.94	19.23	21.19
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	9.95	7.36	6.15	7.34	8.91
Fixed Asset Turnover	0.00	0.00	0.00	2.88	1.59	1.38	2.22	2.49	2.91	3.23
Accounts Payable Turnover	0.00	0.00	1.81	1.03	0.73	1.16	2.26	2.01	2.03	2.45
Days Sales Outstanding (DSO)	0.00	0.00	0.00	12.76	23.63	23.19	16.18	22.90	18.98	17.23
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	36.68	49.56	59.37	49.75	40.96
Days Payable Outstanding (DPO)	0.00	0.00	201.52	353.53	498.17	314.19	161.22	181.25	180.24	149.13
Cash Conversion Cycle (CCC)	0.00	0.00	-201.52	-340.77	-474.54	-254.31	-95.47	-98.97	-111.51	-90.94
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-0.00	0.14	1.97	0.48	8.63	7.08	6.71	6.15	2.30	2.27
Invested Capital Turnover	0.00	0.00	0.23	0.30	0.21	0.18	0.30	0.32	0.51	0.89
Increase / (Decrease) in Invested Capital	0.00	0.14	1.83	-1.49	8.15	-1.54	-0.37	-0.56	-3.85	-0.03
Enterprise Value (EV)	0.00	0.00	143	75	67	29	27	20	88	0.00
Market Capitalization	0.00	0.00	143	75	66	34	29	20	92	0.00
Book Value per Share	$0.00	$0.01	$0.11	$0.03	$1.16	$1.53	$1.09	$0.82	$0.58	$0.57
Tangible Book Value per Share	$0.00	$0.01	$0.02	($0.34)	($0.23)	$0.72	$0.35	$0.10	$0.40	$0.41
Total Capital	0.02	0.14	2.44	0.49	8.78	12	8.69	6.65	6.62	6.84
Total Debt	0.00	0.02	0.04	0.31	1.67	0.12	0.12	0.21	0.19	0.16
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.15	0.10	0.10	0.08	0.06	0.04
Net Debt	-0.03	0.02	-0.43	0.30	1.51	-4.78	-1.87	-0.29	-4.13	-4.41
Capital Expenditures (CapEx)	0.00	0.00	0.00	0.00	0.00	0.08	0.08	0.05	0.09	0.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.00	0.14	-0.25	-1.68	-0.89	-0.19	-0.02	-0.34	-0.37	-0.24
Debt-free Net Working Capital (DFNWC)	0.02	0.14	0.23	-1.67	-0.74	4.70	1.96	0.15	3.94	4.33
Net Working Capital (NWC)	0.02	0.12	0.19	-1.98	-2.25	4.69	1.95	0.02	3.81	4.20
Net Nonoperating Expense (NNE)	0.05	0.80	1.00	1.34	1.12	1.90	1.35	2.07	3.28	2.41
Net Nonoperating Obligations (NNO)	-0.03	0.02	-0.43	0.30	1.51	-4.78	-1.87	-0.29	-4.13	-4.41
Total Depreciation and Amortization (D&A)	0.00	0.00	0.04	0.16	0.44	0.42	0.33	0.29	0.29	0.19
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	-100.78%	-452.66%	-94.31%	-13.48%	-0.99%	-16.45%	-17.39%	-11.86%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	92.73%	-449.91%	-78.20%	330.50%	94.48%	7.19%	184.13%	212.77%
Net Working Capital to Revenue	0.00%	0.00%	76.43%	-533.97%	-238.89%	329.51%	93.53%	1.09%	178.14%	206.44%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.01)	($0.12)	($0.14)	($0.43)	($0.44)	($0.81)	($0.53)	($0.69)	($0.99)	($2.58)
Adjusted Weighted Average Basic Shares Outstanding	24.75M	24.36M	25.31M	6.43M	7.42M	9.12M	8.46M	7.95M	10.61M	11.64M
Adjusted Diluted Earnings per Share	($0.01)	($0.12)	($0.14)	($0.43)	($0.44)	$0.00	$0.00	$0.00	($0.99)	($2.58)
Adjusted Weighted Average Diluted Shares Outstanding	24.75M	24.36M	25.31M	6.43M	7.42M	7.93M	7.83M	10.97M	10.61M	11.64M
Adjusted Basic & Diluted Earnings per Share	($0.01)	($0.12)	($0.14)	($0.43)	($0.44)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	24.75M	22.41M	24.98M	6.33M	6.73M	9.12M	7.83M	10.97M	11.15M	12.16M
Normalized Net Operating Profit after Tax (NOPAT)	-0.11	-0.12	-2.33	-1.38	-1.82	-2.75	-2.90	-3.41	-4.68	-5.82
Normalized NOPAT Margin	0.00%	0.00%	-950.68%	-371.95%	-192.56%	-193.43%	-139.62%	-163.54%	-218.87%	-285.89%
Pre Tax Income Margin	0.00%	0.00%	-1,358.11%	-734.29%	-310.78%	-434.28%	-215.59%	-263.05%	-489.95%	-404.08%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	-36.07	-9.45	-93.45	-540.89	-7.73	-26.41	-369.11
NOPAT to Interest Expense	0.00	0.00	0.00	-18.78	-6.47	-65.41	-377.93	-5.41	-18.49	-258.38
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-36.07	-9.45	-94.69	-550.46	-7.81	-26.65	-369.35
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-18.78	-6.47	-66.66	-387.49	-5.49	-18.72	-258.62
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	-1.69%	-2.65%	0.00%	-1.42%	0.00%

This table displays calculated financial ratios and metrics derived from Nutriband's official financial filings.

Metric	Q2 2023	Q2 2024	Q3 2024	Q1 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026	Q1 2027
Period end date	7/31/2023	7/31/2024	10/31/2023	4/30/2024	10/31/2024	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026
DEI Shares Outstanding	7,833,150.00	11,036,100.00	7,833,150.00	7,833,150.00	11,096,185.00	11,106,185.00	11,154,171.00	11,154,171.00	11,154,171.00	12,155,983.00
DEI Adjusted Shares Outstanding	7,833,150.00	11,036,100.00	7,833,150.00	7,833,150.00	11,096,185.00	11,106,185.00	11,154,171.00	11,154,171.00	11,154,171.00	12,155,983.00
DEI Earnings Per Adjusted Shares Outstanding	-0.11	-0.15	-0.22	-0.24	-0.12	-0.13	-2.14	-0.35	-0.09	-0.10
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	43.80%	-32.49%	-30.77%	0.00%	50.94%	63.37%	0.00%	-46.41%	0.00%	-35.06%
EBITDA Growth	20.76%	-88.25%	-69.49%	0.00%	13.22%	27.18%	0.00%	-168.94%	0.00%	9.26%
EBIT Growth	20.65%	-71.05%	-60.25%	0.00%	17.21%	26.81%	0.00%	-171.95%	0.00%	10.56%
NOPAT Growth	20.31%	-71.05%	-60.85%	0.00%	17.21%	25.19%	0.00%	-171.95%	0.00%	11.26%
Net Income Growth	20.17%	-105.68%	-63.64%	0.00%	22.58%	26.83%	0.00%	-184.18%	0.00%	10.58%
EPS Growth	0.00%	0.00%	0.00%	0.00%	45.45%	42.86%	0.00%	-166.67%	0.00%	16.67%
Operating Cash Flow Growth	-9.54%	0.00%	-0.79%	0.00%	0.00%	-60.32%	0.00%	0.00%	40.95%	57.88%
Free Cash Flow Firm Growth	-192.04%	98.48%	1.51%	0.00%	-275.43%	0.00%	0.00%	129.14%	0.00%	-136.73%
Invested Capital Growth	0.00%	-12.92%	-33.85%	0.00%	22.91%	-55.53%	0.00%	-57.96%	0.00%	-7.64%
Revenue Q/Q Growth	37.53%	0.00%	-3.38%	0.00%	0.00%	0.00%	-6.74%	-44.40%	15.79%	8.16%
EBITDA Q/Q Growth	20.33%	0.00%	-16.63%	0.00%	0.00%	0.00%	-43.50%	-97.21%	74.33%	-22.10%
EBIT Q/Q Growth	18.82%	0.00%	-22.26%	0.00%	0.00%	0.00%	-41.72%	-93.71%	73.69%	-21.16%
NOPAT Q/Q Growth	19.03%	0.00%	-22.26%	0.00%	0.00%	0.00%	-41.72%	-93.71%	73.69%	-22.87%
Net Income Q/Q Growth	18.33%	0.00%	-3.19%	0.00%	0.00%	0.00%	-44.03%	-93.59%	75.00%	-28.29%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1,666.67%	84.91%	93.75%	-400.00%
Operating Cash Flow Q/Q Growth	-32.71%	0.00%	0.00%	-16.11%	0.00%	-7.89%	1.77%	-33.44%	58.24%	23.06%
Free Cash Flow Firm Q/Q Growth	-5,596.10%	0.00%	1,156.13%	0.00%	0.00%	0.00%	-100.00%	0.00%	-100.00%	0.00%
Invested Capital Q/Q Growth	2.51%	0.00%	-21.02%	0.00%	0.00%	0.00%	-27.84%	43.76%	-5.72%	-5.57%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	45.69%	22.93%	37.14%	40.34%	29.58%	37.75%	25.20%	19.80%	22.20%	45.41%
EBITDA Margin	-114.17%	-318.35%	-384.30%	-445.59%	-220.94%	-198.60%	-312.61%	-1,108.85%	-245.82%	-277.52%
Operating Margin	-125.65%	-318.35%	-402.84%	-462.50%	-220.94%	-211.78%	-321.83%	-1,121.30%	-254.78%	-289.42%
EBIT Margin	-125.65%	-318.35%	-402.84%	-462.50%	-220.94%	-207.21%	-321.83%	-1,121.30%	-254.78%	-285.41%
Profit (Net Income) Margin	-126.41%	-385.13%	-411.36%	-464.61%	-211.00%	-208.09%	-321.36%	-1,118.99%	-241.59%	-286.56%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	100.60%	120.98%	102.11%	100.46%	95.50%	100.43%	99.86%	99.79%	94.82%	100.40%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-42.10%	0.00%	0.00%	0.00%	0.00%	-94.34%	0.00%	0.00%	-160.06%	-163.65%
ROIC Less NNEP Spread (ROIC-NNEP)	386.96%	0.00%	0.00%	0.00%	0.00%	-87.03%	0.00%	0.00%	-154.31%	-152.67%
Return on Net Nonoperating Assets (RNNOA)	-6.60%	0.00%	0.00%	0.00%	0.00%	51.51%	0.00%	0.00%	101.88%	91.25%
Return on Equity (ROE)	-48.70%	0.00%	0.00%	0.00%	0.00%	-42.83%	0.00%	0.00%	-58.17%	-72.40%
Cash Return on Invested Capital (CROIC)	-328.83%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-255.07%	-247.97%
Operating Return on Assets (OROA)	-20.63%	0.00%	0.00%	0.00%	0.00%	-46.65%	0.00%	0.00%	-69.10%	-78.88%
Return on Assets (ROA)	-20.76%	0.00%	0.00%	0.00%	0.00%	-46.85%	0.00%	0.00%	-65.53%	-79.20%
Return on Common Equity (ROCE)	-48.70%	0.00%	0.00%	0.00%	0.00%	-42.83%	0.00%	0.00%	-58.16%	-72.38%
Return on Equity Simple (ROE_SIMPLE)	-91.31%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-0.58	-0.99	-1.21	-1.32	-1.00	-0.99	-1.40	-2.72	-0.71	-0.88
NOPAT Margin	-87.96%	-222.84%	-281.99%	-323.75%	-154.66%	-148.25%	-225.28%	-784.91%	-178.34%	-202.60%
Net Nonoperating Expense Percent (NNEP)	-429.05%	-21.51%	-29.58%	-7.06%	-11.09%	-7.31%	-8.77%	-21.71%	-5.75%	-10.98%
Return On Investment Capital (ROIC_SIMPLE)	-	-7.80%	-	-9.75%	-8.74%	-18.72%	-16.17%	-35.19%	-10.44%	-14.28%
Cost of Revenue to Revenue	54.31%	77.07%	62.86%	59.66%	70.42%	62.25%	74.80%	80.20%	77.80%	54.59%
SG&A Expenses to Revenue	103.48%	166.50%	311.08%	264.29%	114.14%	147.14%	256.65%	1,009.00%	230.05%	277.78%
R&D to Revenue	67.86%	174.78%	128.90%	238.55%	136.38%	102.40%	90.38%	132.09%	46.93%	57.05%
Operating Expenses to Revenue	171.34%	341.28%	439.98%	502.84%	250.52%	249.54%	347.03%	1,141.09%	276.97%	334.83%
Earnings before Interest and Taxes (EBIT)	-0.82	-1.41	-1.72	-1.89	-1.43	-1.38	-2.00	-3.88	-1.02	-1.24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-0.75	-1.41	-1.64	-1.82	-1.43	-1.33	-1.95	-3.84	-0.99	-1.20
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.43	5.32	3.09	2.03	6.12	14.97	9.47	9.95	0.00	7.85
Price to Tangible Book Value (P/TBV)	26.68	9.71	0.00	3.52	12.21	24.35	12.30	13.38	0.00	11.51
Price to Revenue (P/Rev)	18.85	0.00	0.00	0.00	0.00	31.86	0.00	0.00	0.00	26.06
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.49	10.13	3.56	3.63	11.04	31.73	43.96	29.05	0.00	20.13
Enterprise Value to Revenue (EV/Rev)	18.77	0.00	0.00	0.00	0.00	30.70	0.00	0.00	0.00	23.93
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.32	0.02	0.04	0.02	0.02	0.04	0.02	0.02	0.02	0.03
Long-Term Debt to Equity	0.30	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Financial Leverage	-0.02	-0.35	-0.24	-0.61	-0.39	-0.59	-0.80	-0.57	-0.66	-0.60
Leverage Ratio	1.43	1.21	1.24	1.13	1.24	1.15	1.20	1.12	1.15	1.18
Compound Leverage Factor	1.44	1.47	1.27	1.14	1.19	1.16	1.20	1.11	1.09	1.18
Debt to Total Capital	24.34%	1.55%	3.58%	1.49%	1.68%	3.43%	2.03%	2.21%	2.41%	2.59%
Short-Term Debt to Total Capital	1.39%	1.01%	2.14%	0.94%	1.12%	2.43%	1.48%	1.67%	1.88%	2.10%
Long-Term Debt to Total Capital	22.95%	0.55%	1.44%	0.55%	0.56%	1.00%	0.55%	0.54%	0.52%	0.49%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%	0.04%	0.04%	0.05%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	75.66%	98.45%	96.42%	98.51%	98.32%	96.57%	97.94%	97.76%	97.55%	97.36%
Debt to EBITDA	-0.37	0.00	0.00	0.00	0.00	-0.02	0.00	0.00	-0.02	-0.02
Net Debt to EBITDA	0.02	0.00	0.00	0.00	0.00	0.29	0.00	0.00	0.54	0.48
Long-Term Debt to EBITDA	-0.35	0.00	0.00	0.00	0.00	-0.01	0.00	0.00	0.00	0.00
Debt to NOPAT	-0.51	0.00	0.00	0.00	0.00	-0.03	0.00	0.00	-0.03	-0.03
Net Debt to NOPAT	0.03	0.00	0.00	0.00	0.00	0.41	0.00	0.00	0.76	0.67
Long-Term Debt to NOPAT	-0.48	0.00	0.00	0.00	0.00	-0.01	0.00	0.00	-0.01	-0.01
Altman Z-Score	2.88	0.00	0.00	0.00	0.00	34.78	0.00	0.00	0.00	21.79
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.02%	0.03%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.75	6.57	2.79	6.16	4.96	3.71	4.78	7.53	6.36	5.26
Quick Ratio	2.93	6.19	2.00	5.95	4.65	3.31	4.55	7.07	5.98	4.82
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-7.35	-0.11	1.18	0.00	-2.07	1.91	0.00	0.60	0.00	-0.70
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	-13,461.28%	0.00%	-25,112.17%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-795.89	-0.30	29.29	0.00	-512.50	324.41	0.00	108.49	0.00	-139.92
Operating Cash Flow to Interest Expense	-107.76	0.00	-10.74	-96.77	0.00	-227.38	-227.50	-315.88	-137.20	-112.44
Operating Cash Flow Less CapEx to Interest Expense	-107.76	0.00	-9.68	-97.48	0.00	-228.28	-227.50	-315.88	-137.20	-112.44
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.16	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.27	0.28
Accounts Receivable Turnover	7.25	0.00	0.00	0.00	0.00	26.76	0.00	0.00	21.19	37.26
Inventory Turnover	6.03	0.00	0.00	0.00	0.00	8.17	0.00	0.00	8.91	7.67
Fixed Asset Turnover	2.01	0.00	0.00	0.00	0.00	3.43	0.00	0.00	3.23	2.99
Accounts Payable Turnover	1.91	0.00	0.00	0.00	0.00	1.83	0.00	0.00	2.45	1.90
Days Sales Outstanding (DSO)	50.32	0.00	0.00	0.00	0.00	13.64	0.00	0.00	17.23	9.80
Days Inventory Outstanding (DIO)	60.48	0.00	0.00	0.00	0.00	44.68	0.00	0.00	40.96	47.60
Days Payable Outstanding (DPO)	191.48	0.00	0.00	0.00	0.00	199.71	0.00	0.00	149.13	192.30
Cash Conversion Cycle (CCC)	-80.68	0.00	0.00	0.00	0.00	-141.39	0.00	0.00	-90.94	-134.91
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	6.77	5.90	4.66	5.22	5.73	2.32	1.67	2.41	2.27	2.14
Invested Capital Turnover	0.48	0.00	0.00	0.00	0.00	0.64	0.00	0.00	0.90	0.81
Increase / (Decrease) in Invested Capital	6.77	-0.88	-2.38	0.00	1.07	-2.90	0.00	-3.32	0.00	-0.18
Enterprise Value (EV)	30	60	17	19	63	74	74	70	0.00	43
Market Capitalization	31	66	18	27	69	76	80	75	0.00	47
Book Value per Share	$0.88	$1.13	$0.73	$1.71	$1.01	$0.46	$0.76	$0.63	$0.57	$0.49
Tangible Book Value per Share	$0.15	$0.62	$0.00	$0.98	$0.51	$0.28	$0.59	$0.47	$0.41	$0.34
Total Capital	9.11	13	5.92	14	11	5.28	8.67	7.72	6.84	6.15
Total Debt	2.22	0.20	0.21	0.20	0.19	0.18	0.18	0.17	0.16	0.16
Total Long-Term Debt	2.09	0.07	0.09	0.07	0.06	0.05	0.05	0.04	0.04	0.03
Net Debt	-0.12	-6.56	-1.05	-8.15	-5.51	-2.78	-6.82	-5.14	-4.41	-3.85
Capital Expenditures (CapEx)	0.00	0.00	-0.04	0.01	0.00	0.01	0.00	0.00	0.00	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.19	-0.49	0.14	-0.91	-0.63	-0.33	-0.92	-0.14	-0.24	-0.33
Debt-free Net Working Capital (DFNWC)	2.53	6.27	1.41	7.44	5.07	2.63	6.08	5.17	4.33	3.67
Net Working Capital (NWC)	2.40	6.14	1.28	7.31	4.94	2.50	5.95	5.04	4.20	3.54
Net Nonoperating Expense (NNE)	0.25	0.72	0.55	0.58	0.36	0.40	0.60	1.16	0.25	0.36
Net Nonoperating Obligations (NNO)	-0.12	-6.56	-1.05	-8.15	-5.51	-2.78	-6.82	-5.14	-4.41	-3.85
Total Depreciation and Amortization (D&A)	0.08	0.00	0.08	0.07	0.00	0.06	0.06	0.04	0.04	0.03
Debt-free, Cash-free Net Working Capital to Revenue	11.82%	0.00%	0.00%	0.00%	0.00%	-13.81%	0.00%	0.00%	-11.86%	-18.46%
Debt-free Net Working Capital to Revenue	155.84%	0.00%	0.00%	0.00%	0.00%	109.78%	0.00%	0.00%	212.77%	203.78%
Net Working Capital to Revenue	148.03%	0.00%	0.00%	0.00%	0.00%	104.43%	0.00%	0.00%	206.44%	196.61%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.11)	($0.15)	($0.22)	($0.21)	($0.12)	($0.12)	($2.12)	($0.32)	($0.02)	($0.10)
Adjusted Weighted Average Basic Shares Outstanding	7.83M	11.06M	7.83M	9.16M	11.10M	11.13M	11.22M	12.06M	11.64M	12.16M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($0.12)	($0.12)	($2.12)	($0.32)	($0.02)	($0.10)
Adjusted Weighted Average Diluted Shares Outstanding	7.83M	11.10M	7.83M	11.04M	11.10M	11.13M	11.22M	12.06M	11.64M	12.16M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	7.83M	11.10M	7.83M	11.04M	11.11M	11.15M	12.03M	12.17M	12.16M	12.16M
Normalized Net Operating Profit after Tax (NOPAT)	-0.58	-0.99	-1.21	-1.32	-1.00	-0.99	-1.40	-2.72	-0.71	-0.88
Normalized NOPAT Margin	-87.96%	-222.84%	-281.99%	-323.75%	-154.66%	-148.25%	-225.28%	-784.91%	-178.34%	-202.60%
Pre Tax Income Margin	-126.41%	-385.13%	-411.36%	-464.61%	-211.00%	-208.09%	-321.36%	-1,118.99%	-241.59%	-286.56%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-89.25	-3.78	-42.87	-219.25	-353.97	-235.20	-347.00	-699.41	-191.40	-246.99
NOPAT to Interest Expense	-62.47	-2.65	-30.01	-153.47	-247.78	-168.27	-242.90	-489.59	-133.98	-175.33
EBIT Less CapEx to Interest Expense	-89.25	0.00	-41.82	-219.97	0.00	-236.11	-347.00	-699.41	-191.40	-246.99
NOPAT Less CapEx to Interest Expense	-62.47	0.00	-28.96	-154.19	0.00	-169.18	-242.90	-489.59	-133.98	-175.33
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Nutriband Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Nutriband's fiscal year ends in January. Their fiscal year 2026 ended on January 31, 2026.

Nutriband's net income appears to be on an upward trend, with a most recent value of -$8.23 million in 2026, rising from -$151.26 thousand in 2017. The previous period was -$10.48 million in 2025. See where experts think Nutriband is headed by visiting Nutriband's forecast page.

Nutriband's total operating income in 2026 was -$8.32 million, based on the following breakdown:

Total Gross Profit: $566.31 thousand
Total Operating Expenses: $8.88 million

Over the last 9 years, Nutriband's total revenue changed from $0.00 in 2017 to $2.04 million in 2026, a change of 203,665,100.0%.

Nutriband's total liabilities were at $868.45 thousand at the end of 2026, a 16.6% decrease from 2025, and a 7,259.7% increase since 2016.

In the past 10 years, Nutriband's cash and equivalents has ranged from $0.00 in 2018 to $4.89 million in 2022, and is currently $4.57 million as of their latest financial filing in 2026.

Over the last 9 years, Nutriband's book value per share changed from 0.00 in 2017 to 0.57 in 2026, a change of 57,250.0%.

Related Companies

Financial statements for NASDAQ:NTRB last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nutriband (NTRB) Financials

Financials Breakdown Chart

Nutriband Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nutriband (NTRB) Financials

Annual Income Statements for Nutriband

Quarterly Income Statements for Nutriband

Annual Cash Flow Statements for Nutriband

Quarterly Cash Flow Statements for Nutriband

Annual Balance Sheets for Nutriband

Quarterly Balance Sheets for Nutriband

Annual Metrics And Ratios for Nutriband

Quarterly Metrics And Ratios for Nutriband

Financials Breakdown Chart

Nutriband Financials - Frequently Asked Questions

When does Nutriband's financial year end?

How has Nutriband's net income changed over the last 9 years?

What is Nutriband's operating income?

How has Nutriband's revenue changed over the last 9 years?

How much debt does Nutriband have?

How much cash does Nutriband have?

How has Nutriband's book value per share changed over the last 9 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools